Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Benign Prostatic Hyperplasia (BPH) Treatment Devices by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Benign Prostatic Hyperplasia (BPH) Treatment Devices by Country/Region, 2017, 2022 & 2028

2.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Segment by Type

2.2.1 Surgical Treatment

2.2.2 Minimally Invasive Treatment

2.2.3 Laser Treatment

2.2.4 Other

2.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type

2.3.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2017-2022)

2.3.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Market Share by Type (2017-2022)

2.3.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sale Price by Type (2017-2022)

2.4 Benign Prostatic Hyperplasia (BPH) Treatment Devices Segment by Application

2.4.1 Fertility Clinics

2.4.2 Hospitals

2.4.3 Others

2.5 Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application

2.5.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sale Market Share by Application (2017-2022)

2.5.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Market Share by Application (2017-2022)

2.5.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sale Price by Application (2017-2022)

3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices by Company

3.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Breakdown Data by Company

3.1.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Annual Sales by Company (2020-2022)

3.1.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Company (2020-2022)

3.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Annual Revenue by Company (2020-2022)

3.2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Company (2020-2022)

3.2.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Company (2020-2022)

3.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sale Price by Company

3.4 Key Manufacturers Benign Prostatic Hyperplasia (BPH) Treatment Devices Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Location Distribution

3.4.2 Players Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Benign Prostatic Hyperplasia (BPH) Treatment Devices by Geographic Region

4.1 World Historic Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size by Geographic Region (2017-2022)

4.1.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Annual Revenue by Geographic Region

4.2 World Historic Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size by Country/Region (2017-2022)

4.2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Annual Sales by Country/Region (2017-2022)

4.2.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Annual Revenue by Country/Region

4.3 Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth

4.4 APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth

4.5 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth

4.6 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth

5 Americas

5.1 Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country

5.1.1 Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2017-2022)

5.1.2 Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country (2017-2022)

5.2 Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type

5.3 Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region

6.1.1 APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region (2017-2022)

6.1.2 APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Region (2017-2022)

6.2 APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type

6.3 APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices by Country

7.1.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2017-2022)

7.1.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country (2017-2022)

7.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type

7.3 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices by Country

8.1.1 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2017-2022)

8.1.2 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country (2017-2022)

8.2 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type

8.3 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Benign Prostatic Hyperplasia (BPH) Treatment Devices

10.3 Manufacturing Process Analysis of Benign Prostatic Hyperplasia (BPH) Treatment Devices

10.4 Industry Chain Structure of Benign Prostatic Hyperplasia (BPH) Treatment Devices

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Distributors

11.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Customer

12 World Forecast Review for Benign Prostatic Hyperplasia (BPH) Treatment Devices by Geographic Region

12.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Forecast by Region

12.1.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Forecast by Region (2023-2028)

12.1.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Forecast by Type

12.7 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Forecast by Application

13 Key Players Analysis

13.1 Advin Urology

13.1.1 Advin Urology Company Information

13.1.2 Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

13.1.3 Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Advin Urology Main Business Overview

13.1.5 Advin Urology Latest Developments

13.2 Biolitec

13.2.1 Biolitec Company Information

13.2.2 Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

13.2.3 Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Biolitec Main Business Overview

13.2.5 Biolitec Latest Developments

13.3 Boston Scientific Corporation

13.3.1 Boston Scientific Corporation Company Information

13.3.2 Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

13.3.3 Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Boston Scientific Corporation Main Business Overview

13.3.5 Boston Scientific Corporation Latest Developments

13.4 CONMED

13.4.1 CONMED Company Information

13.4.2 CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

13.4.3 CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 CONMED Main Business Overview

13.4.5 CONMED Latest Developments

13.5 Convergent Laser Technologies

13.5.1 Convergent Laser Technologies Company Information

13.5.2 Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

13.5.3 Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Convergent Laser Technologies Main Business Overview

13.5.5 Convergent Laser Technologies Latest Developments

13.6 CoreTherm Medical, Inc. (ProstaLund)

13.6.1 CoreTherm Medical, Inc. (ProstaLund) Company Information

13.6.2 CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

13.6.3 CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 CoreTherm Medical, Inc. (ProstaLund) Main Business Overview

13.6.5 CoreTherm Medical, Inc. (ProstaLund) Latest Developments

13.7 HistoSonics, Inc.

13.7.1 HistoSonics, Inc. Company Information

13.7.2 HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

13.7.3 HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 HistoSonics, Inc. Main Business Overview

13.7.5 HistoSonics, Inc. Latest Developments

13.8 JenaSurgical GmbH

13.8.1 JenaSurgical GmbH Company Information

13.8.2 JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

13.8.3 JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 JenaSurgical GmbH Main Business Overview

13.8.5 JenaSurgical GmbH Latest Developments

13.9 KARL STORZ

13.9.1 KARL STORZ Company Information

13.9.2 KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

13.9.3 KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 KARL STORZ Main Business Overview

13.9.5 KARL STORZ Latest Developments

13.10 LISA Laser Products GmbH

13.10.1 LISA Laser Products GmbH Company Information

13.10.2 LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

13.10.3 LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 LISA Laser Products GmbH Main Business Overview

13.10.5 LISA Laser Products GmbH Latest Developments

13.11 Lumenis Ltd.

13.11.1 Lumenis Ltd. Company Information

13.11.2 Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

13.11.3 Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Lumenis Ltd. Main Business Overview

13.11.5 Lumenis Ltd. Latest Developments

13.12 Medifocus, Inc.

13.12.1 Medifocus, Inc. Company Information

13.12.2 Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

13.12.3 Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Medifocus, Inc. Main Business Overview

13.12.5 Medifocus, Inc. Latest Developments

13.13 Endo International

13.13.1 Endo International Company Information

13.13.2 Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

13.13.3 Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Endo International Main Business Overview

13.13.5 Endo International Latest Developments

13.14 Medtronic

13.14.1 Medtronic Company Information

13.14.2 Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

13.14.3 Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Medtronic Main Business Overview

13.14.5 Medtronic Latest Developments

13.15 Siemens

13.15.1 Siemens Company Information

13.15.2 Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

13.15.3 Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Siemens Main Business Overview

13.15.5 Siemens Latest Developments

13.16 Olympus

13.16.1 Olympus Company Information

13.16.2 Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

13.16.3 Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Olympus Main Business Overview

13.16.5 Olympus Latest Developments

13.17 Urologix

13.17.1 Urologix Company Information

13.17.2 Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

13.17.3 Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Urologix Main Business Overview

13.17.5 Urologix Latest Developments

13.18 NeoTract

13.18.1 NeoTract Company Information

13.18.2 NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

13.18.3 NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 NeoTract Main Business Overview

13.18.5 NeoTract Latest Developments

13.19 Urotech

13.19.1 Urotech Company Information

13.19.2 Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

13.19.3 Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Urotech Main Business Overview

13.19.5 Urotech Latest Developments

13.20 Baxter International

13.20.1 Baxter International Company Information

13.20.2 Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

13.20.3 Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Baxter International Main Business Overview

13.20.5 Baxter International Latest Developments

14 Research Findings and Conclusion

Table 1. Benign Prostatic Hyperplasia (BPH) Treatment Devices Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Benign Prostatic Hyperplasia (BPH) Treatment Devices Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Surgical Treatment

Table 4. Major Players of Minimally Invasive Treatment

Table 5. Major Players of Laser Treatment

Table 6. Major Players of Other

Table 7. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2017-2022) & (K Units)

Table 8. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2017-2022)

Table 9. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Type (2017-2022) & ($ million)

Table 10. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Type (2017-2022)

Table 11. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sale Price by Type (2017-2022) & (US$/Unit)

Table 12. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2017-2022) & (K Units)

Table 13. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2017-2022)

Table 14. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Application (2017-2022)

Table 15. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Application (2017-2022)

Table 16. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sale Price by Application (2017-2022) & (US$/Unit)

Table 17. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Company (2020-2022) & (K Units)

Table 18. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Company (2020-2022)

Table 19. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Company (2020-2022)

Table 21. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sale Price by Company (2020-2022) & (US$/Unit)

Table 22. Key Manufacturers Benign Prostatic Hyperplasia (BPH) Treatment Devices Producing Area Distribution and Sales Area

Table 23. Players Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered

Table 24. Benign Prostatic Hyperplasia (BPH) Treatment Devices Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share Geographic Region (2017-2022)

Table 29. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Country/Region (2017-2022)

Table 33. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2017-2022) & (K Units)

Table 36. Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Country (2017-2022)

Table 37. Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Country (2017-2022)

Table 39. Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2017-2022) & (K Units)

Table 40. Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2017-2022)

Table 41. Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2017-2022) & (K Units)

Table 42. Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2017-2022)

Table 43. APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region (2017-2022) & (K Units)

Table 44. APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Region (2017-2022)

Table 45. APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Region (2017-2022)

Table 47. APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2017-2022) & (K Units)

Table 48. APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2017-2022)

Table 49. APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2017-2022) & (K Units)

Table 50. APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2017-2022)

Table 51. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2017-2022) & (K Units)

Table 52. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Country (2017-2022)

Table 53. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Country (2017-2022)

Table 55. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2017-2022) & (K Units)

Table 56. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2017-2022)

Table 57. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2017-2022) & (K Units)

Table 58. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Benign Prostatic Hyperplasia (BPH) Treatment Devices

Table 68. Key Market Challenges & Risks of Benign Prostatic Hyperplasia (BPH) Treatment Devices

Table 69. Key Industry Trends of Benign Prostatic Hyperplasia (BPH) Treatment Devices

Table 70. Benign Prostatic Hyperplasia (BPH) Treatment Devices Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Benign Prostatic Hyperplasia (BPH) Treatment Devices Distributors List

Table 73. Benign Prostatic Hyperplasia (BPH) Treatment Devices Customer List

Table 74. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Forecast by Region

Table 76. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share Forecast by Application (2023-2028)

Table 94. Advin Urology Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors

Table 95. Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

Table 96. Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 97. Advin Urology Main Business

Table 98. Advin Urology Latest Developments

Table 99. Biolitec Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors

Table 100. Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

Table 101. Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 102. Biolitec Main Business

Table 103. Biolitec Latest Developments

Table 104. Boston Scientific Corporation Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors

Table 105. Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

Table 106. Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 107. Boston Scientific Corporation Main Business

Table 108. Boston Scientific Corporation Latest Developments

Table 109. CONMED Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors

Table 110. CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

Table 111. CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 112. CONMED Main Business

Table 113. CONMED Latest Developments

Table 114. Convergent Laser Technologies Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors

Table 115. Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

Table 116. Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 117. Convergent Laser Technologies Main Business

Table 118. Convergent Laser Technologies Latest Developments

Table 119. CoreTherm Medical, Inc. (ProstaLund) Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors

Table 120. CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

Table 121. CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 122. CoreTherm Medical, Inc. (ProstaLund) Main Business

Table 123. CoreTherm Medical, Inc. (ProstaLund) Latest Developments

Table 124. HistoSonics, Inc. Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors

Table 125. HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

Table 126. HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 127. HistoSonics, Inc. Main Business

Table 128. HistoSonics, Inc. Latest Developments

Table 129. JenaSurgical GmbH Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors

Table 130. JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

Table 131. JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 132. JenaSurgical GmbH Main Business

Table 133. JenaSurgical GmbH Latest Developments

Table 134. KARL STORZ Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors

Table 135. KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

Table 136. KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 137. KARL STORZ Main Business

Table 138. KARL STORZ Latest Developments

Table 139. LISA Laser Products GmbH Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors

Table 140. LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

Table 141. LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 142. LISA Laser Products GmbH Main Business

Table 143. LISA Laser Products GmbH Latest Developments

Table 144. Lumenis Ltd. Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors

Table 145. Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

Table 146. Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 147. Lumenis Ltd. Main Business

Table 148. Lumenis Ltd. Latest Developments

Table 149. Medifocus, Inc. Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors

Table 150. Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

Table 151. Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 152. Medifocus, Inc. Main Business

Table 153. Medifocus, Inc. Latest Developments

Table 154. Endo International Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors

Table 155. Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

Table 156. Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 157. Endo International Main Business

Table 158. Endo International Latest Developments

Table 159. Medtronic Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors

Table 160. Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

Table 161. Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 162. Medtronic Main Business

Table 163. Medtronic Latest Developments

Table 164. Siemens Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors

Table 165. Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

Table 166. Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 167. Siemens Main Business

Table 168. Siemens Latest Developments

Table 169. Olympus Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors

Table 170. Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

Table 171. Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 172. Olympus Main Business

Table 173. Olympus Latest Developments

Table 174. Urologix Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors

Table 175. Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

Table 176. Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 177. Urologix Main Business

Table 178. Urologix Latest Developments

Table 179. NeoTract Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors

Table 180. NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

Table 181. NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 182. NeoTract Main Business

Table 183. NeoTract Latest Developments

Table 184. Urotech Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors

Table 185. Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

Table 186. Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 187. Urotech Main Business

Table 188. Urotech Latest Developments

Table 189. Baxter International Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors

Table 190. Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offered

Table 191. Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 192. Baxter International Main Business

Table 193. Baxter International Latest Developments

List of Figures

Figure 1. Picture of Benign Prostatic Hyperplasia (BPH) Treatment Devices

Figure 2. Benign Prostatic Hyperplasia (BPH) Treatment Devices Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Surgical Treatment

Figure 10. Product Picture of Minimally Invasive Treatment

Figure 11. Product Picture of Laser Treatment

Figure 12. Product Picture of Other

Figure 13. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type in 2021

Figure 14. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Type (2017-2022)

Figure 15. Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumed in Fertility Clinics

Figure 16. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market: Fertility Clinics (2017-2022) & (K Units)

Figure 17. Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumed in Hospitals

Figure 18. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market: Hospitals (2017-2022) & (K Units)

Figure 19. Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumed in Others

Figure 20. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market: Others (2017-2022) & (K Units)

Figure 21. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2017-2022)

Figure 22. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Application in 2021

Figure 23. Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Company in 2021

Figure 25. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Geographic Region in 2021

Figure 27. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Region (2017-2022)

Figure 28. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Country/Region in 2021

Figure 29. Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales 2017-2022 (K Units)

Figure 30. Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue 2017-2022 ($ Millions)

Figure 31. APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales 2017-2022 (K Units)

Figure 32. APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue 2017-2022 ($ Millions)

Figure 33. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales 2017-2022 (K Units)

Figure 34. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales 2017-2022 (K Units)

Figure 36. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue 2017-2022 ($ Millions)

Figure 37. Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Country in 2021

Figure 38. Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Country in 2021

Figure 39. United States Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Region in 2021

Figure 44. APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Regions in 2021

Figure 45. China Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Country in 2021

Figure 52. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Country in 2021

Figure 53. Germany Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Country in 2021

Figure 60. Egypt Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Benign Prostatic Hyperplasia (BPH) Treatment Devices in 2021

Figure 66. Manufacturing Process Analysis of Benign Prostatic Hyperplasia (BPH) Treatment Devices

Figure 67. Industry Chain Structure of Benign Prostatic Hyperplasia (BPH) Treatment Devices

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles